IP Library › Granted Patent US 11,911,491
Granted Patent B2
US 11,911,491 · App. 17/365,286 · Granted Feb 27, 2024

Sunscreen formulation

Inventors: David J. Milora (Blue Bell, PA); Harry Fallick (Wayne, PA)
Assignee: FALLIEN COSMECEUTICALS, LTD.
A61K8/046A61K8/0241A61K8/19A61K8/27A61K8/29A61K8/37A61K8/375A61K8/4993A61K8/60A61K8/731A61K8/8147A61K8/8152A61K8/8176A61K8/85A61K8/86A61K8/87A61Q17/04A61K2800/21A61K2800/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,911,491
App. No.
17/365,286
Granted
Feb 27, 2024
Kind
B2
Abstract

The present application relates to sunscreen formulations, including foamable sunscreen formulations, that comprise zinc oxide and titanium dioxide particles, suitably in the size range of about 1-100 nm. The compositions suitably produce a minimal residual whitening effect when applied to a skin surface.

Claims (45)

1. A foamable sunscreen formulation consisting essentially of:

a) zinc oxide particles having a primary particle size of about 100 nm to about 500 nm;

b) titanium dioxide particles having a primary particle size of about 100 nm to about 500 nm;

c) about 0.05 wt % to about 15 wt % emulsion stabilizer;

d) about 0.05 wt % to about 25 wt % skin conditioner;

e) about 0.05 wt % to about 20 wt emulsifier;

f) about 0.1 wt % to about 20 wt % suspending agent; and

g) the remainder water,

wherein the formulation produces a minimal residual whitening effect when applied to a skin surface.

2. The foamable sunscreen formulation of claim 1 , wherein the zinc oxide particles are about 1 wt % to about 25 wt % of the formulation.

3. The foamable sunscreen formulation of claim 1 , wherein the titanium dioxide particles are about 1 wt % to about 25 wt % of the formulation.

4. The foamable sunscreen formulation of claim 1 , wherein the emulsion stabilizer is selected from microcrystalline cellulose, cellulose gum, xanthan gum, magnesium aluminum silicate, bentonite clay, hectorite clay, and combination thereof.

5. The foamable sunscreen formulation of claim 1 , wherein the skin conditioner is selected from C 12-15 alkyl benzoate, octyldodecyl neopentanoate, butyl octyl salicylate, caprylyl glycol, glycerin, fatty acid esters of C 8 or greater, mineral oil, a triglyceride, and combination thereof.

6. The foamable sunscreen formulation of claim 1 , wherein the emulsifier is selected from glyceryl stearate, ceteareth-20, polysorbate 80, sodium lauryl sulfate, lecithin, and combination thereof.

7. The foamable sunscreen formulation of claim 1 , wherein the suspending agent is selected from polyhydroxystearic acid, sodium polyacrylate polymer, methyl methacrylate crosspolymer, and combination thereof.

8. The foamable sunscreen formulation of claim 1 , further consisting essentially of iron oxide particles, a film former, or both.

9. A foamable sunscreen formulation consisting essentially of:

a) about 3 wt % to about 20 wt % zinc oxide particles having a primary particle size of about 100 nm to about 500 nm;

b) about 3 wt % to about 20 wt % titanium dioxide particles having a primary particle size of about 100 nm to about 500 nm;

c) about 0.05 wt % to about 10 wt % emulsion stabilizer;

d) about 0.1 wt % to about 25 wt % skin conditioner;

e) about 0.1 wt % to about 20 wt % emulsifier;

f) about 0.1 wt % to about 15 wt % suspending agent; and

g) the remainder water,

wherein the formulation produces a minimal residual whitening effect when applied to a skin surface.

10. The foamable sunscreen formulation of claim 9 , wherein the emulsion stabilizer is selected from microcrystalline cellulose, cellulose gum, xanthan gum, magnesium aluminum silicate, bentonite clay, hectorite clay, and combination thereof.

11. The foamable sunscreen formulation of claim 9 , wherein the skin conditioner is selected from C 12-15 alkyl benzoate, octyldodecyl neopentanoate, butyl octyl salicylate, caprylyl glycol, glycerin, fatty acid esters of C 8 or greater, mineral oil, a triglyceride, and combination thereof.

12. The foamable sunscreen formulation of claim 9 , wherein the emulsifier is selected from glyceryl stearate, ceteareth-20, polysorbate 80, sodium lauryl sulfate, lecithin, and combination thereof.

13. The foamable sunscreen formulation of claim 9 , wherein the suspending agent is selected from polyhydroxystearic acid, sodium polyacrylate polymer, methyl methacrylate crosspolymer, and combination thereof.

14. The foamable sunscreen formulation of claim 9 , further consisting essentially of about 0.01 wt % to about 1 wt % iron oxide particles.

15. The foamable sunscreen formulation of claim 9 , further consisting essentially of a film former.

16. The foamable sunscreen formulation of claim 15 , wherein the film former is selected from polyurethane-2, polymethyl methacrylate, tricontanyl poly(vinyl pyrollidone) (PVP), vinyl pyrollidone/eicosene copolymer, and combination thereof.

17. A foamable sunscreen formulation consisting essentially of:

a) about 3 wt % to about 20 wt % zinc oxide particles having a primary particle size of about 100 nm to about 500 nm;

b) about 3 wt % to about 20 wt % titanium dioxide particles having a primary particle size of about 100 nm to about 500 nm;

c) about 0.05 wt % to about 15 wt % emulsion stabilizer;

d) about 0.05 wt % to about 25 wt % skin conditioner;

e) about 0.05 wt % to about 20 wt % emulsifier;

f) about 0.1 wt % to about 20 wt % suspending agent;

g) about 0.1 wt % to about 20 wt % film former; and

h) the remainder water,

wherein the formulation produces a minimal residual whitening effect when applied to a skin surface.

18. The foamable sunscreen formulation of claim 17 , wherein the skin conditioner comprises butyl octyl salicylate, glycerin, a triglyceride, or a combination thereof.

19. The foamable sunscreen formulation of claim 17 , wherein the suspending agent comprises polyhydroxystearic acid.

20. The foamable sunscreen formulation of claim 17 , wherein the film former comprises vinyl pyrollidone/eicosene copolymer.

Assignments (2)
CHANGE OF ADDRESS OF APPLICANT Recorded Apr 19, 2022
From: FALLIEN COSMECEUTICALS, LTD.
To: FALLIEN COSMECEUTICALS, LTD.
Reel/Frame 059727/0145 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2022
From: MILORA, DAVID J.; FALLICK, HARRY
To: FALLIEN COSMECEUTICALS, LTD.
Reel/Frame 059606/0904 →
Continuity (7)
Continuation 16581998 · Sep 25, 2019
Continuation 15856190 · Dec 28, 2017
Continuation 15387709 · Dec 22, 2016
Continuation 14539217 · Nov 12, 2014
Continuation 13648707 · Oct 10, 2012
Provisional Application 61545848 · Oct 11, 2011
Related Publication 20220023161A1 · Jan 27, 2022
Cited By (1)
US 12,728,081